Eiger BioPharmaceuticals (EIGR) Enters $25M Stock Sales Agreement
Tweet Send to a Friend
Eiger BioPharmaceuticals (NASDAQ: EIGR) disclosed in an SEC filing on Thursday:On June 17, 2016, Eiger BioPharmaceuticals, Inc. (the “Company”) entered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
